HARIMAYA KENZO

No ORCID on file · 16 papers in corpus · active 1998
1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…

1998
Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same

Sesquiterpene derivatives, represented by the following formulae (I) and (II), having progesterone receptor binding inhibitory activity are disclosed. They can be used as therapeutic and prophylactic agents for progesterone-related diseases…